Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation

@article{Pomerleau1985NeuroregulatorsAT,
  title={Neuroregulators and the reinforcement of smoking: Towards a biobehavioral explanation},
  author={Ovide F. Pomerleau and Cynthia Stodola Pomerleau},
  journal={Neuroscience \& Biobehavioral Reviews},
  year={1985},
  volume={8},
  pages={503-513}
}
Neuroregulatory effects of nicotine
Research on stress and smoking: progress and problems.
TLDR
The integration of behavioural, physiological, and biochemical research exemplified by the above approach should lead to a better understanding of stress and smoking.
Endogenous opioids and smoking: A review of progress and problems
  • O. Pomerleau
  • Biology, Psychology
    Psychoneuroendocrinology
  • 1998
Co-factors for smoking and evolutionary psychobiology.
TLDR
A better understanding of the evolutionary psychobiology of smoking may promote development of tailored interventions for smokers with co-factors and nicotine may have therapeutic applications for non-smokers with co -factors.
Naltrexone alteration of the nicotine-induced EEG and mood activation response in tobacco-deprived cigarette smokers.
  • V. Knott, D. Fisher
  • Psychology, Biology
    Experimental and clinical psychopharmacology
  • 2007
TLDR
The findings suggest that the opioid system is involved in nicotine-induced subjective and neuroelectric arousal and implicate opioid-cholinergic interactions in the elicitation of these arousal responses to nicotine.
β-Endorphin and drug-induced reward and reinforcement
Nicotine and smoking: a perspective from animal studies
  • P. Clarke
  • Psychology, Biology
    Psychopharmacology
  • 2004
TLDR
Clinical evidence suggests that smoking cessation would be facilitated by the administration of a Nicotinic antagonist having a selective action on central nicotinic cholinoceptors of the C6 (ganglionic) type, and Pharmacological studies in animals indicate that such a drug is a reasonable prospect.
Nicotine and Endogenous Opioids: Toward Specific Pharmacotherapy
TLDR
The role of opioid antagonism on smoking behaviour is unclear, despite the publication of 5 trials on the subject, and psychiatrists can hope to have a more specific pharmacotherapy to address the cravings and short-term rewards of nicotine use.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Effect of naloxone on change in breathing pattern with smoking. A hypothesis on the addictive nature of cigarette smoking.
TLDR
Using respiratory inductive plethysmography to noninvasively monitor the breathing pattern, the effects of smoking on VT/TI after intravenous (IV) injection of naloxone (2 mg), a specific opiate antagonist, and placebo are compared.
Effect of smoking and nicotine on adrenocortical secretion.
TLDR
The effect of tobacco smoking and nicotine administration on the secretory activity of the adrenal cortex was studied in man and in animals and it is suggested that this stimulation of adrenocortical activity is due to enhanced corticotropin release resulting from a nicotine-induced increase in sympathetic and catecholamine activity.
Stress-induced analgesia: Neural and hormonal determinants
The effects of nicotine on brain neurotransmitter systems.
Reinforcing and other behavioral effects of nicotine
Naloxone reduces cigarette smoking.
The role of endorphins in stress: Evidence and speculations
...
1
2
3
4
5
...